fig5

Figure 5. Subtype-specific analysis in BRAF-mutated rare tumors. (A and B) Oncoprint displaying gene mutations (cutoff 5%; A) and mutation frequency diagrams in MAPK and RTKs for hairy-cell leukemia (B); (C and D) Oncoprint displaying gene mutations (cutoff 5%; C) and mutation frequency diagram in MAPK and RTKs for ganglioglioma (D); (E and F) Oncoprint displaying gene mutations (cutoff 5%; E) and mutation frequency diagram in MAPK and RTKs for serous borderline ovarian tumor (F). In each box, the red color intensity is proportional to the mutation frequency of the gene. RTKs: Receptor tyrosine kinases; ATM: ataxia-telangiectasia mutated.